Ambalal Sarabhai Enterprises Ltd (AMBALALSA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Ambalal Sarabhai Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited (Standalone ....
Intimation · 05 Nov 2026, 5:30 am
Ambalal Sarabhai Enterprises Schedules Board Meeting for Q2 FY27 Results Ambalal Sarabhai Enterprises Limited announced that its Board of Directors will meet on 5th Nov'26 to consider and approve the standalone and consolidated unaudited financial results, along with the Limited Review Report, for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities remains closed for designated persons and their immediate relatives from 1st Oct'26 through 7th Nov'26 (both days inclusive) in compliance with insider trading regulations.
We hereby submit Quarterly Snapshot (Q26 Vs. Q25). Kindly take the same on your records.
Others (Uncategorized) · 13 Aug 2026, 11:19 pm
Ambalal Sarabhai Q1FY27 Results: Strong QoQ Profitability Growth Ambalal Sarabhai Enterprises reported strong QoQ performance for the quarter ended 30th Jun'26. Excluding certain other income from the prior quarter, Total Income grew 8% QoQ to ₹4,559.02 L from ₹4,205.04 L. EBITDA surged 106% QoQ to ₹657.07 L, with the margin at 14.41%. Profit Before Tax (PBT) saw a significant 263% QoQ increase to ₹467.86 L from ₹128.73 L in the previous quarter, indicating a substantial improvement in operational profitability.
We hereby submit unaudited financial results (standalone and consolidated) for the quarter ended 30.06.2026 along with limited review report from auditors thereon. Kindly take the same ....
Financial Result · 12 Aug 2026, 10:24 pm
Ambalal Sarabhai Q1FY27 Results: PAT Declines Amidst Higher Revenue Ambalal Sarabhai Enterprises reported consolidated results for Q1FY27 ending 30-Jun'26. Revenue from operations grew 8.0% YoY to ₹4,356.26 lakhs, while total income fell 6.4% to ₹4,559.02 lakhs. A significant decline in other income and a 33.8% QoQ rise in expenses pressured profitability. Consequently, Net Profit After Tax (PAT) declined 51.7% YoY and 38.8% QoQ to ₹397.58 lakhs. Consolidated EPS for the quarter stood at ₹0.52, down from ₹1.07 YoY and ₹0.85 QoQ. The board approved these results on 12-Aug'26.
We hereby submit outcome of Board Meeting held on 12.08.2026. Kindly take the same on your records.
Outcome · 12 Aug 2026, 10:18 pm
Ambalal Sarabhai Enterprises Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 4,356 (+8.0% YoY | -33.5% QoQ) ■ EBITDA: 454 (+206.9% YoY | -20.2% QoQ) ■ EBITDA Margin (%): 10.4 (+676 bps YoY | +173 bps QoQ) ■ PAT: 398 (-51.7% YoY | -38.8% QoQ) ■ EPS (INR): 0.52 (-51.4% YoY | -38.8% QoQ) Ambalal Sarabhai Enterprises Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) Segmental Performance Pharmaceuticals ■ Revenue: 2,526 (-0.8% YoY | -16.7% QoQ) ■ EBIT: 438 (-47.7% YoY | +17.6% QoQ) ■ EBIT Margin (%): 17.4 (-1554 bps YoY | +506 bps QoQ) Electronics ■ Revenue: 1,833 (+23.2% YoY | -47.9% QoQ) ■ EBIT: 127 (+126.1% YoY | -67.8% QoQ) ■ EBIT Margin (%): 6.9 (+316 bps YoY | -428 bps QoQ)
We here by submit a Clarification on Price Movement. Kindly take the same on your records.
Others (Uncategorized) · 06 Aug 2026, 8:17 pm
Ambalal Sarabhai Enterprises Clarifies Recent Stock Price Movement In response to an exchange query on 06-Aug'26, Ambalal Sarabhai Enterprises stated it has no unpublished price-sensitive information or impending announcements that could explain the recent significant price movement. The company confirmed compliance with SEBI LODR regulations, having disclosed all material information. Management attributes the share price volatility purely to market-driven factors and reaffirmed its commitment to timely future disclosures as required.
We hereby submit revised date of plant visit and other details. Kindly take the same on your records.
Others (Uncategorized) · 05 Aug 2026, 8:08 pm
Ambalal Sarabhai Enterprises Reschedules Shareholder Plant Visit Ambalal Sarabhai Enterprises has rescheduled its shareholder plant visit to its Ranoli facility. The visit, originally planned for 26th Oct'26, will now occur on 01st Dec'26, from 3:00 p.m. to 5:00 p.m. The change was made following shareholder requests to accommodate the Diwali festival. Interested shareholders must register their participation by 13th Nov'26. This investor relations event offers shareholders a direct view of the company's manufacturing operations.
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial ....
Intimation · 12 Aug 2026, 5:30 am
Ambalal Sarabhai Board Meeting Set for Q1 Results Ambalal Sarabhai Enterprises has scheduled a board meeting on 12 Aug'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. A Limited Review Report from the auditors will also be presented. The company has closed its trading window for designated persons from 01 Jul'26 to 14 Aug'26, inclusive.
We hereby submit Scrutinizer''s Report. Kindly take the same on your records.
Annual General Meeting · 31 Jul 2026, 8:56 pm
Ambalal Sarabhai: All Resolutions Passed at 48th AGM Ambalal Sarabhai Enterprises announced that all nine resolutions proposed at its 48th AGM on 30th Jul'26 were passed with overwhelming majority, securing over 99.8% of votes in favour. Key approvals include the adoption of FY26 financial statements, re-appointment of directors, and special resolutions approving loans and guarantees to related parties Synbiotics Limited, Asence Pharma, and Systronics India. Overall voter turnout was 33.71%, with promoters voting 100% in favour across all resolutions, ensuring their passage.
We hereby submit outcome of the 48th Annual General Meeting. Kindly take the same on your records.
Annual General Meeting · 30 Jul 2026, 6:24 pm
Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that subsequent to the submission of the Annual Report for ....
Others (Uncategorized) · 08 Jul 2026, 9:50 pm
We hereby submit Annual Report for 48th AGM of the Company to be held on 30.07.2026. Kindly take the same on your records.
Others (Uncategorized) · 07 Jul 2026, 3:54 pm
We hereby submit details for Annual General Meeting of the Company. Kindly take the same on your records.
Annual General Meeting · 22 May 2026, 1:25 am
Ambalal Sarabhai Q4FY26 PAT Jumps to ₹650.11 Lakhs, FY26 PAT Up 261% YoY Ambalal Sarabhai Enterprises reported Q4FY26 consolidated PAT of ₹650.11 lakhs vs a loss of ₹26.70 lakhs YoY. Revenue from operations grew 1.0% YoY to ₹6,548.73 lakhs. For FY26, PAT surged 261% YoY to ₹1,780.32 lakhs, while revenue increased 3.1% YoY to ₹20,227.17 lakhs. EPS for FY26 stood at ₹2.32, up from ₹0.64 in FY25. The Board has also announced its 48th AGM will be held on 30th Jul'26, with 23rd Jul'26 as the e-voting cut-off date.
We hereby Submit details of re-appointments as per the attached file. Kindly take the same on your records.
Change in Management · 22 May 2026, 1:21 am
Ambalal Sarabhai Enterprises Q4FY26 PAT Jumps, Key Managerial Reappointments Proposed For Q4FY26, Ambalal Sarabhai Enterprises reported a consolidated PAT of ₹650.1cr, a significant turnaround from a loss of ₹26.7cr YoY. Revenue from operations increased marginally to ₹6,548.7cr from ₹6,481.4cr YoY. For FY26, PAT surged to ₹1,780.3cr from ₹493.2cr in FY25, while revenue grew to ₹20,227.2cr from ₹19,618.5cr. The board approved reappointments including Kartikeya V. Sarabhai as Executive Chairman, Mohal K. Sarabhai as MD, and Chaula M. Shastri as Whole-time Director. The 48th AGM is scheduled for 30th Jul'26.
We here by submit Financial Results (Standalone and Consolidated) for the Quarter and Year ended 31.03.2026 along with Auditors Report thereon. Kindly take the same on your records.
Financial Result · 22 May 2026, 1:00 am
Ambalal Sarabhai Reports FY26 Results; Key Management Reappointments Approved Ambalal Sarabhai Enterprises reported Q4 FY26 consolidated net profit of ₹650.11 lakhs, reversing a loss of ₹26.70 lakhs YoY. Revenue from operations grew 1.0% YoY to ₹6,548.73 lakhs. For FY26, net profit surged 261% YoY to ₹1,780.32 lakhs, while revenue increased 3.1% to ₹20,227.17 lakhs. The Board approved the reappointments of Mr. Kartikeya V. Sarabhai as Executive Chairman and Mr. Mohal K. Sarabhai as Managing Director. The 48th AGM is scheduled for 30th Jul'26, with 23rd Jul'26 as the e-voting cut-off date.
Outcome of Board Meeting
Outcome · 22 May 2026, 12:51 am
Ambalal Sarabhai Enterprises Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 6,549 (+1.0% YoY | +25.9% QoQ) ■ EBITDA: 570 (+5.3% YoY | +39.7% QoQ) ■ EBITDA Margin (%): 8.7 (+35 bps YoY | +86 bps QoQ) ■ PAT: 650 (Loss to Profit YoY | +78.7% QoQ) ■ EPS (INR): 0.85 (Loss to Profit YoY | +80.9% QoQ) Ambalal Sarabhai Enterprises Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) Segmental Performance Pharmaceuticals ■ Revenue: 3,034 (+7.0% YoY | +5.8% QoQ) ■ EBIT: 373 (Loss to Profit YoY | +65.3% QoQ) ■ EBIT Margin (%): 12.3 (Loss to Profit YoY | +443 bps QoQ) Electronics ■ Revenue: 3,515 (-3.6% YoY | +50.7% QoQ) ■ EBIT: 394 (-36.1% YoY | +9.0% QoQ) ■ EBIT Margin (%): 11.2 (-570 bps YoY | -430 bps QoQ)
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Audited Financial ....
Intimation · 21 May 2026, 5:30 am
Ambalal Sarabhai Enterprises to Announce Q4 & FY26 Results on 21-May-26 Ambalal Sarabhai Enterprises (BSE: 500009) has scheduled a Board Meeting for Thu, 21-May-26 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31-Mar-26. The agenda also includes fixing the date for the Annual General Meeting and book closure. The trading window for designated persons is closed from 01-Apr-26 to 23-May-26, inclusive.
Intimation regarding change in Branch Address of RTA
Others (Uncategorized) · 24 Apr 2026, 11:11 pm
Ambalal Sarabhai Enterprises: Registrar & Transfer Agent Address Change Ambalal Sarabhai Enterprises (BSE: 500009) announced on 24 Apr '26 a change in its Registrar & Share Transfer Agent's (RTA) branch address. The RTA, MCS Share Transfer Agent Ltd, has relocated its operations from Baroda to a new Mumbai office at Andheri (E). All investor servicing and share registry work will now be handled from the Mumbai branch. This administrative change centralizes shareholder services to a major financial hub, potentially impacting communication and processing timelines for investors.
<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Others (Uncategorized) · 21 Apr 2026, 9:26 pm
Ambalal Sarabhai Enterprises Discloses Nil Incremental Borrowing for FY26 Ambalal Sarabhai Enterprises filed its annual disclosure as a Large Corporate on 21-Apr'26 for FY 2025-26. The company reported nil incremental borrowing for the year, resulting in a mandatory debt securities borrowing requirement of zero. Consequently, there was no shortfall in meeting the SEBI-mandated fundraising norms. The disclosure, covering the three-year block from FY 2023-24 to FY 2025-26, also confirmed that no penalty is applicable for the period, indicating compliance with the regulatory framework.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 21 Apr 2026, 9:20 pm
Ambalal Sarabhai Enterprises Not Classified as a Large Corporate for FY26 Ambalal Sarabhai Enterprises Ltd informed exchanges on 21-Apr'26 that it does not qualify as a Large Corporate (LC) for the financial year ending 31-Mar'26, as per SEBI's framework. Consequently, the mandatory fundraising requirements through debt securities are not applicable to the company. This declaration confirms its exclusion from the specific SEBI regulations governing Large Corporates.
We hereby submit the Outcome of Board Meeting held on 12.02.2026. Kindly take the same on your records.
Outcome · 12 Feb 2026, 11:37 pm
Ambalal Sarabhai Q3 FY26 Results: Net Profit Surges YoY Ambalal Sarabhai Enterprises reported a consolidated net profit of ₹363.89 lakhs for Q3 FY26 ended 31st Dec'25, a 63% YoY increase from ₹223.17 lakhs. Revenue from operations grew 13% YoY to ₹5,199.64 lakhs. The company recorded an exceptional item of ₹81.99 lakhs related to the impact of new labour codes. For the nine months ended Dec'25, net profit surged 117% YoY to ₹1,130.21 lakhs on a 4% revenue increase. Consolidated EPS for the quarter stood at ₹0.40.
We hereby submit financial Result (Standalone and Consolidated) for the quarter and nine months ended 31.12.2025 along with Limited Review Report of Auditors thereon. Kindly take the ....
Financial Result · 12 Feb 2026, 11:34 pm
Ambalal Sarabhai Enterprises Limited - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) ■ Revenue: 5200 (+13.1% YoY | +17.0% QoQ) ■ EBITDA: 408 (Loss to Profit YoY | +701.0% QoQ) ■ EBITDA Margin (%): 7.8 (Loss to Profit YoY | +670 bps QoQ) ■ PAT: 306 (+37.2% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.40 (+37.9% YoY | Loss to Profit QoQ) Ambalal Sarabhai Enterprises Limited - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lakhs) Segmental Performance Pharmaceuticals ■ Revenue: 2868 (+0.2% YoY | +10.2% QoQ) ■ EBIT: 226 (-13.2% YoY | Loss to Profit QoQ) ■ EBIT Margin (%): 7.9 (-121 bps YoY | Loss to Profit QoQ) Electronics ■ Revenue: 2332 (+34.5% YoY | +26.5% QoQ) ■ EBIT: 362 (+146.6% YoY | +69.6% QoQ) ■ EBIT Margin (%): 15.5 (+706 bps YoY | +395 bps QoQ)
Ambalal Sarabhai Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Unaudited Financial ....
Intimation · 12 Feb 2026, 5:30 am
Ambalal Sarabhai Enterprises Sets Board Meeting for Q3 FY26 Results Ambalal Sarabhai Enterprises (BSE: 500009) will hold a Board of Directors meeting on 12 Feb'26. The agenda includes consideration and approval of the unaudited standalone and consolidated financial results for the quarter and nine months ending 31 Dec'25. In connection with this, the trading window for designated persons is closed from 01 Jan'26 to 14 Feb'26, inclusive.
We hereby submit Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30.09.2025 along with Limited Review Report of Auditors thereon. Kindly take ....
Financial Result · 13 Nov 2025, 2:28 am
We hereby submit outcome of the Board Meeting held on 12.11.2025. Kindly take the same on your records.
Outcome · 13 Nov 2025, 2:21 am
We hereby submit announcement under Regulation 30 of SEBI (LODR) Regulations, 2015. Kindly take the same on your records.
Others (Uncategorized) · 06 Nov 2025, 4:15 pm